Chicago-based biotech Cour Pharmaceuticals announced the hiring of former Acelyrin executive Paul M. Peloso, MD as chief medical officer Tuesday morning. Peloso is an industry veteran, having most ...
CHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class, disease-modifying therapies designed to induce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results